Understanding disparities in cerebral atherosclerosis mortality across the United States: An analysis of the CDC

Antony A Fuleihan1, Joanna M Roy2, Justin Do3

  • 1Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA; Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

Insights

Cerebral atherosclerosis mortality shows significant racial and demographic disparities in death location. Nursing homes and homes are most common, but access to preferred end-of-life care varies by race.

Area of Science:

  • Neurology
  • Public Health
  • Gerontology

Background:

  • Cerebral atherosclerosis is a major cause of ischemic stroke.
  • Mortality and prevalence vary across demographics.
  • No prior studies assessed death location for this condition.

Purpose of the Study:

  • Evaluate mortality trends in the U.S.
  • Assess racial disparities in death location.
  • Analyze factors influencing where individuals die from cerebral atherosclerosis.

Main Methods:

  • Utilized CDC WONDER database (1999-2022).
  • Analyzed deaths with cerebral atherosclerosis as underlying or contributing cause.
  • Employed multinomial logistic regression to determine factors affecting death location.

Main Results:

  • Over 160,000 deaths analyzed; predominantly White, female, and elderly (≥85 years).
  • Most common death locations: nursing homes (42.2%) and home (38.4%).
  • Older age increased out-of-hospital deaths; African Americans had lower odds of dying at home or in nursing homes.

Conclusions:

  • Significant demographic and racial disparities exist in death locations for cerebral atherosclerosis.
  • Findings underscore the need for interventions addressing end-of-life care disparities.
  • Improved access to preferred death settings is crucial, especially for minority populations.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
39
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
57
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
36
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35